drugset / Trial / NCT02837939
Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction
Phase 2/3
Withdrawn
Martin Janičko
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
This study is aimed to assess the efficacy of Human derived Transfer factor ( T-lymphocytes homogenate that contains small molecular weight (10 kDa) molecules: various IFNs, ILs, chemokines, endorfins, heat shock proteins) in decreasing rate and/or severity of infections in acute or chronic decompensations of liver cirrhosis and acute on chronic liver failure..
Timeline
- Start
- 2016-07
- Primary completion
- 2025-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human derived Transfer factor | Unknown | 2e+08 cells | Subcutaneous |